Skip to Main Content
Contribute Try STAT+ Today

A controversial Philadelphia ordinance that would have required sales reps to become licensed, prevented drug makers from giving gifts to doctors, and prohibited distribution of copay coupons for controlled substances was voted down amid lobbying by restaurants and pharmaceutical companies.

The ordinance, which was designed to blunt the effects of the opioid crisis, was defeated even after it was amended to pertain only to companies selling prescription drugs that are addictive, but not every drug manufacturer (more here). The final vote was 9 to 5, with two abstentions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.